Well Referenced

Tag: Abnoba Viscum

Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study

This large-scale observational study evaluated the safety of intravenous mistletoe preparations (Helixor, Abnoba viscum, Iscador) in 475 oncology patients. Over 4,500 infusions were analyzed. Adverse drug reactions (ADRs) were reported in 4.6% of patients, with 59.4% of these being mild and 40.6% moderate; no severe ADRs were observed. ADRs occurred

Read More »
June 26, 2025 No Comments

Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology

This study investigates the safety and adverse effects of intratumoral (IT) mistletoe injections in 123 cancer patients, examining the incidence and severity of adverse drug reactions (ADRs) from 862 injections using preparations like Abnoba Viscum and Helixor. The study found that 21.1% of patients experienced mild ADRs, including localized reactions

Read More »
June 26, 2025 No Comments